Alyson
Wooten, PharmD, focuses her practice on patent litigation with a special emphasis on
pharmaceutical patent litigation under the Hatch-Waxman Act. Registered
as a patent attorney and pharmacist, Dr. Wooten also has broad experience in
counseling clients on FDA regulatory matters, clinical trial management, early
commercialization strategies, patent settlements and licenses, drug products
liability, and antitrust issues bearing on pharmaceutical patent settlements.
Prior to joining Kilpatrick Townsend, Dr. Wooten worked for a leading
pharmaceutical company focusing on Paragraph IV litigation, patent prosecution
for new chemical entities, and FDA regulatory issues.
|